Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

Scientific literature on COVID-19 Test Methods and Devices - detail

A Rapid High-Sensitivity SARS-CoV-2 Nucleocapsid Immunoassay to Aid Diagnosis of Acute COVID-19 at the Point of Care: A Clinical Performance

Detection Principle
ImmunoAssay-Antigen
Target
nucleocapside protein
Testing Method Category
Other
Testing Method
LumiraDx SARS-CoV-2 antigen
Testing Method - Additional Info
microfluidic immunoassay to detect the nucleocapsid protein of SARS-CoV-2. Comparison to rt-PCR Roche cobas 6800 platform
Reported Performance
nasal swab test: sensitivity 97.6% specificity96.6%. nasopharyngeal swab: sensitivity 97.5%; specificity 97.7%
Sample Size
512 patients
Peer-reviewed
yes

The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements